Advertisement
Screener

ePlus inc. (PLUS) Spending and interest coverage

ePlus inc. (PLUS) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 0.51%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months0.51%Share-based compensation / revenue. Period ending 2026-06-30.

$12.59M ÷ $2.45B × 100 ≈ 0.51%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue2.45B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation12.59M USDShare-based Payment Arrangement, Noncash Expense
Operating income162.04M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)$2.45B$12.59M$162.04M(m)(m)0.51%(m)(m)
2026-03-31(m)$2.44B$12.13M$166.15M(m)(m)0.50%(m)(m)
2025-12-31(m)$2.35B$11.46M$157.95M(m)(m)0.49%(m)(m)
2025-09-30(m)$2.29B$11.17M$167.99M(m)(m)0.49%(m)(m)
2025-06-30(m)$2.17B$10.64M$146.15M(m)(m)0.49%(m)(m)
2025-03-31(m)$2.07B$10.00M$141.41M(m)(m)0.48%(m)(m)
2024-12-31(m)$2.13B$10.97M$135.71M(m)(m)0.52%(m)(m)
2024-09-30(m)$2.12B$10.56M$145.25M(m)(m)0.50%(m)(m)
2024-06-30(m)$2.20B$10.38M$147.39M(m)(m)0.47%(m)(m)
2024-03-31(m)$2.23B$9.73M$158.26M$3.78M(m)0.44%41.90×Reported
2023-12-31(m)$2.16B$9.29M$171.66M$4.32M(m)0.43%39.70×Reported
2023-09-30(m)$2.28B$8.71M$180.07M$4.92M(m)0.38%36.63×Reported
2023-06-30(m)$2.18B$8.26M$179.31M$4.62M(m)0.38%38.80×Reported
2023-03-31(m)$2.07B$7.83M$166.16M$4.13M(m)0.38%40.20×Reported
2022-12-31(m)$2.03B$7.44M$158.22M$3.50M(m)0.37%45.16×Reported
2022-09-30(m)$1.90B$7.27M$147.85M$2.49M(m)0.38%59.38×Reported
2022-06-30(m)$1.86B$7.15M$148.05M$1.91M(m)0.38%77.63×Reported
2022-03-31(m)$1.82B$7.11M$147.32M$1.90M(m)0.39%77.41×Reported
2021-12-31(m)$1.72B$7.10M$136.43M$2.09M(m)0.41%65.34×Reported
2021-09-30(m)$1.65B$7.10M$129.61M$1.88M(m)0.43%68.87×Reported
2021-06-30(m)$1.63B$7.02M$113.79M$1.79M(m)0.43%63.68×Reported
2021-03-31(m)$1.57B$7.17M$106.33M$2.00M(m)0.46%53.03×Reported
2020-12-31(m)$1.58B$7.36M$100.62M$1.85M(m)0.47%54.24×Reported
2020-09-30(m)$1.58B$7.55M$97.63M$2.19M(m)0.48%44.50×Reported
2020-06-30(m)$1.56B$7.92M$97.52M$2.52M(m)0.51%38.65×Reported
2020-03-31(m)$1.59B$7.95M$95.28M$2.57M(m)0.50%37.02×Reported
2019-12-31(m)$1.55B$7.84M$91.87M$2.44M(m)0.51%37.61×Reported
2019-09-30(m)$1.46B$7.74M$85.63M$2.19M(m)0.53%39.06×Reported
2019-06-30(m)$1.40B$7.47M$81.82M$2.10M(m)0.53%38.96×Reported
2019-03-31(m)$1.37B$7.24M$79.53M$1.95M(m)0.53%40.83×Reported
2018-12-31(m)(m)$7.03M$83.58M(m)(m)(m)(m)(m)
2018-09-30(m)(m)$6.84M$79.94M(m)(m)(m)(m)(m)
2018-06-30(m)$1.40B$6.65M$84.20M(m)(m)0.47%(m)(m)
2018-03-31(m)$1.41B$6.46M$84.24M(m)(m)0.46%(m)(m)
2017-12-31(m)$1.41B$6.36M$84.46M(m)(m)0.45%(m)(m)
2017-09-30(m)$1.40B$6.30M$89.38M(m)(m)0.45%(m)(m)
2017-06-30(m)$1.40B$6.07M$88.75M(m)(m)0.43%(m)(m)
2017-03-31(m)$1.33B$6.03M$85.73M(m)(m)0.45%(m)(m)
2016-12-31(m)$1.30B$6.02M$83.38M(m)(m)0.46%(m)(m)
2016-09-30(m)$1.27B$5.90M$79.71M(m)(m)0.47%(m)(m)
2016-06-30(m)$1.23B$5.94M$78.17M(m)(m)0.48%(m)(m)
2016-03-31(m)$1.20B$5.71M$75.75M(m)(m)0.47%(m)(m)
2015-12-31(m)$1.17B$5.37M$74.45M(m)(m)0.46%(m)(m)
2015-09-30(m)$1.18B$5.05M$77.37M(m)(m)0.43%(m)(m)
2015-06-30(m)$1.14B$4.77M$71.03M(m)(m)0.42%(m)(m)
2015-03-31(m)$1.14B$4.58M$70.71M(m)(m)0.40%(m)(m)
2014-12-31(m)$1.14B$4.43M(m)(m)(m)0.39%(m)(m)
2014-09-30(m)$1.10B$4.26M(m)(m)(m)0.39%(m)(m)
2014-06-30(m)$1.07B$4.13M(m)(m)(m)0.39%(m)(m)
2014-03-31(m)$1.06B$3.97M(m)(m)(m)0.38%(m)(m)
2013-12-31(m)$1.03B$3.75M(m)(m)(m)0.36%(m)(m)
2013-09-30(m)$1.01B$3.66M(m)(m)(m)0.36%(m)(m)
2013-06-30(m)$997.71M$3.50M(m)(m)(m)0.35%(m)(m)
2013-03-31(m)$983.11M$3.28M(m)(m)(m)0.33%(m)(m)
2012-12-31(m)$965.80M$3.15M(m)(m)(m)0.33%(m)(m)
2012-09-30(m)$947.80M$2.89M(m)(m)(m)0.30%(m)(m)
2012-06-30(m)$891.41M$2.63M(m)(m)(m)0.29%(m)(m)
2012-03-31(m)$825.58M$2.39M(m)(m)(m)0.29%(m)(m)
2011-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-03-31(m)$718.51M$1.26M(m)(m)(m)0.18%(m)(m)
2010-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-03-31(m)$550.61M$474.00K(m)(m)(m)0.09%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
PC CONNECTION INC (CNXN)United States$2.247B19.22
SCANSOURCE, INC. (SCSC)United States$1.169B13.32
Climb Global Solutions, Inc. (CLMB)United States$0.582B21.12
Ingram Micro Holding Corp (INGM)United States$6.077B15.03
TD SYNNEX CORP (SNX)United States$20.761B18.48